Halozyme's market cap is currently $7.37B. The company's EPS TTM is $3.432; its P/E ratio is 16.83; Halozyme is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $0.96. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 1.02B	$ 829.25M	$ 660.12M	$ 443.31M	$ 267.59M
Gross Profit	$ 855.91M	$ 636.89M	$ 520.81M	$ 361.90M	$ 224.23M
Operating Income	$ 551.48M	$ 337.57M	$ 267.53M	$ 275.90M	$ 144.25M
EBITDA	$ 551.48M	$ 451.95M	$ 315.51M	$ 259.04M	$ 152.96M
Net Income	$ 444.09M	$ 281.59M	$ 202.13M	$ 402.71M	$ 129.09M
Balance Sheet
Cash & Short-Term Investments	$ 596.07M	$ 336.00M	$ 362.79M	$ 740.92M	$ 368.01M
Total Assets	$ 2.06B	$ 1.73B	$ 1.84B	$ 1.10B	$ 579.92M
Total Debt	$ 0.00	$ 1.50B	$ 1.51B	$ 876.67M	$ 397.23M
Net Debt	$ -115.85M	$ 1.38B	$ 1.27B	$ 757.96M	$ 249.53M
Total Liabilities	$ 1.70B	$ 1.65B	$ 1.67B	$ 907.48M	$ 428.88M
Stockholders' Equity	$ 363.82M	$ 83.81M	$ 169.80M	$ 196.95M	$ 151.05M
Cash Flow
Free Cash Flow	$ 468.37M	$ 373.28M	$ 235.30M	$ 297.98M	$ 52.95M
Operating Cash Flow	$ 479.06M	$ 388.57M	$ 240.11M	$ 299.44M	$ 55.45M
Investing Cash Flow	$ -262.72M	$ -96.91M	$ -487.00M	$ -406.29M	$ 78.35M
Financing Cash Flow	$ -218.86M	$ -407.99M	$ 362.37M	$ 77.86M	$ -106.28M

Currency in USD

Halozyme Earnings and Revenue History

Income Statement >

Halozyme Debt to Assets

Balance Sheet >

Halozyme Cash Flow

Cash Flow >

Halozyme Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing